---
title: "MediciNova Announces Completion of Last Patient Last Visit in the MN-001-NATG-202 Clinical Trial of MN-001 (Tipelukast) | MNOV Stock News"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/287687352.md"
description: "MediciNova Announces Completion of Last Patient Last Visit in the MN-001-NATG-202 Clinical Trial of MN-001 (Tipelukast) | MNOV Stock News"
datetime: "2026-05-26T15:00:57.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/287687352.md)
  - [en](https://longbridge.com/en/news/287687352.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/287687352.md)
generator: "portal-rs"
---

# MediciNova Announces Completion of Last Patient Last Visit in the MN-001-NATG-202 Clinical Trial of MN-001 (Tipelukast) | MNOV Stock News

MediciNova Announces Completion of Last Patient Last Visit in the MN-001-NATG-202 Clinical Trial of MN-001 (Tipelukast) | MNOV Stock News

### Related Stocks

- [4875.JP](https://longbridge.com/en/quote/4875.JP.md)
- [MNOV.US](https://longbridge.com/en/quote/MNOV.US.md)

## Related News & Research

- [BridgeBio Pharma (BBIO) Stock Looks Fully Priced Despite Strong Sales Growth](https://longbridge.com/en/news/297731949.md)
- [Gyre Therapeutics outlines protein degrader pipeline, China commercial outlook in corporate presentation](https://longbridge.com/en/news/297654775.md)
- [5 Stocks In The Spotlight From Wall Street's Most Accurate Analysts Last Month](https://longbridge.com/en/news/297615620.md)
- [BiomX set to execute 1-for-10 reverse stock split Sept. 9](https://longbridge.com/en/news/297659721.md)
- [CollPlant Biotechnologies Implements 1-for-10 Reverse Share Split to Maintain Nasdaq Listing](https://longbridge.com/en/news/297698987.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**